<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Clinical research / Drug discovery / Pharmaceuticals policy / Pharmacology / European Medicines Agency / Orphan drug / Clinical trial / Medical device / Medicine / Pharmaceutical sciences / Health
Date: 2013-07-17 20:40:14
Pharmaceutical industry
Clinical research
Drug discovery
Pharmaceuticals policy
Pharmacology
European Medicines Agency
Orphan drug
Clinical trial
Medical device
Medicine
Pharmaceutical sciences
Health

Consultation submission: Baxter Healthcare Pty Ltd

Add to Reading List

Source URL: www.anztpa.org

Download Document from Source Website

File Size: 94,84 KB

Share Document on Facebook

Similar Documents

The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DocID: 1vrLd - View Document

7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme

DocID: 1vlIp - View Document

The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP

DocID: 1ucvu - View Document

2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use

DocID: 1sVev - View Document

European Medicines Agency: Celebrating 20 years

DocID: 1sUY9 - View Document